Your browser doesn't support javascript.
loading
Combination of solifenacin with tamsulosin reduces prostate volume and vascularity as opposed to tamsulosin monotherapy in patients with benign prostate enlargement and overactive bladder symptoms: Results from a randomized pilot study.
Sakalis, Vasileios; Sfiggas, Vasileios; Vouros, Ioannis; Salpiggidis, George; Papathanasiou, Athanasios; Apostolidis, Apostolos.
Afiliação
  • Sakalis V; Department of Urology, Hippokration Hospital, Thessaloniki, Greece.
  • Sfiggas V; Department of Urology, Hippokration Hospital, Thessaloniki, Greece.
  • Vouros I; Department of Urology, Hippokration Hospital, Thessaloniki, Greece.
  • Salpiggidis G; Department of Urology, Hippokration Hospital, Thessaloniki, Greece.
  • Papathanasiou A; Department of Urology, Hippokration Hospital, Thessaloniki, Greece.
  • Apostolidis A; 2nd Department of Urology, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Int J Urol ; 25(8): 737-745, 2018 08.
Article em En | MEDLINE | ID: mdl-30008188

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa / Succinato de Solifenacina / Tansulosina Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa / Succinato de Solifenacina / Tansulosina Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article